FDA's role in the evaluation of Avandia's safety [[electronic resource] ] : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007

• Pubblicazione: Washington : , : U.S. G.P.O., , 2009
• Descrizione fisica: iii, 138 pages : digital, PDF file
• Soggetto topico: Rosiglitazone - Side effects; Diabetes - Chemotherapy; Drugs - United States - Testing
• Note generali: Title from title screen (viewed on Mar. 20, 2009).; Paper version available for sale by the Supt. of Docs., U.S. G.P.O.; "Serial no. 110-76."
• Nota di bibliografia: Includes bibliographical references (page 23).
• Altri titoli varianti: FDA's role in the evaluation of Avandia's safety
• Titolo autorizzato: FDA's role in the evaluation of Avandia's safety
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910693458503321
• Lo trovi qui: Univ. Federico II